Abstract
AbstractFor Brazil, there are no nationwide data on HPV prevalence against which the impact of the HPV immunization program can be measured in the future. Therefore, we aim to evaluate the prevalence of genital HPV infection among adolescents and young adults in Brazil. A cross-sectional, multicentric, nationwide survey was conducted between September 2016 and November 2017. Sexually active unvaccinated women and men aged 16 to 25 years old were recruited from 119 public primary care units, including all 26 state capitals and the Federal District. All participants answered a face-to-face interview and provided biological samples for genital HPV analysis. We used an automated DNA extraction method and HPV genotyping was performed using the Linear Array genotyping test (Roche). Of 7,694 participants, 53.6% (95% CI 51.4–55.8) were positive for any HPV type. The prevalence of high-risk HPV types was significantly higher in women (38.6% vs. 29.2%, P < 0·001). The HPV types included in the quadrivalent vaccine were detected in 1002 (14.8%) specimens, with a different pattern of HPV infection between sexes. Characteristics associated with overall HPV detection included female gender, self-declaration of race as brown/pardo, lower socioeconomic class, single or dating, current smoking and having 2 or more sex partners in the past year. We found a high prevalence of HPV, with significant differences between regions. Our data provide information that may be considered when developing HPV prevention policies and constitute a baseline against which the impact of the HPV immunization program in Brazil can be measured in future years.
Funder
Luisa Lina Villa is a member of the Board for HPV vaccines for Merck, Sharp & Dohme and a consultant for BD, Roche, and Qiagen for HPV tests.
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Forman, D. et al. Global Burden of Human Papillomavirus and Related Diseases. Vaccine 30, F12–F23 (2012).
2. Bosch, F. X., Lorincz, A., Muñoz, N., Meijer, C. J. L. M. & Shah, K. V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55, 244–265 (2002).
3. Chaturvedi, A. K. Global burden of human papillomavirus-positive head and neck cancers. Lancet Oncol. 15, 1282–1283 (2014).
4. INCA - Instituto Nacional de Câncer - Estimativa 2016, http://www.inca.gov.br/estimativa/2016/sintese-de-resultados-comentarios.asp (2018).
5. Ginsburg, O. M. Breast and cervical cancer control in low and middle-income countries: Human rights meet sound health policy. J. Cancer Policy 1, e35–e41 (2013).
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献